Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2010
06/22/2010US7741488 Tetrahydropyridothiophenes as antiproliferative agents for the treatment of cancer
06/22/2010US7741487 reacting a perylene-3,4-dicarboximide wtih a perylene-3,4-dicarboximide containing x goup ( x=hydrogen, bromine or chlorine) in the presence of a base-stable, high-boiling, organic solvent and of an alkali metal base or alkaline earth metal base( e.g potassium tert-butoxide); cost efficiency
06/22/2010US7741341 Benzimidazole-derivatives as factor Xa inhibitors
06/22/2010US7741340 Hydroxy piperidine derivatives to treat gaucher disease
06/22/2010US7741339 Fab I inhibitors
06/22/2010US7741333 (3-bromophenyl)-(3,3-dioxo-2,3-dihydro-1H-3 lambda 6-thia-6,8-diazacyclopenta[a]naphthalen-9-yl)amine, uses as inhibitors of protein kinases
06/22/2010US7741332 Brain and nervous system disorders such as mood disorders or urinary incontinence, pain, anxiety, hearing loss; 2-(carbonylamino)-1,1-dioxo-1H-benzo[1,2,4]thiadiazines, 4-(oxo or thiooxo)-3-(carbonylamino)-quinazolines, and 1-(oxo or thiooxo)-2-(carbonylamino)-1,2-dihydroisoquinolines
06/22/2010US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
06/22/2010US7741325 Benzo[b]chromeno-naphthyridin-7-one and pyrano[2′,3′:7,8]quino[2,3-b]quinoxalin-7-one compounds
06/22/2010CA2540834C Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
06/22/2010CA2523253C Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2412718C Viral polymerase inhibitors
06/22/2010CA2411716C 1,3,8-triaza-spiro [4.5] decan derivatives
06/22/2010CA2398988C Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient
06/22/2010CA2395095C Triazatrinaphthyrins and the use thereof
06/22/2010CA2389553C Heteroaryl-diazabicycloalkanes
06/17/2010WO2010068806A1 Amide derivatives as btk inhibitors in the treatment of allergic, autoimmune and inflammatory disorders as well as cancer
06/17/2010WO2010068480A1 Deuterated derivatives of dimeboline
06/17/2010WO2010068453A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
06/17/2010WO2010068452A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
06/17/2010WO2010067085A2 Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-υ-carboline and analogues and intermediates
06/17/2010WO2010066832A1 Triple substituted phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases or conditions, or cancer
06/17/2010WO2010066780A1 Spiroheterocyclic n-oxypiperidines as pesticides
06/17/2010WO2010066684A2 Pyridyloxyindoles Inhibitors of VEGF-R2 and Use Thereof for Treatment of Disease
06/17/2010WO2010066658A1 Compounds which potentiate the ampa receptor and uses thereof in medicine
06/17/2010WO2010066380A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010WO2010031184A8 Azaindole derivatives as crth2 receptor antagonists
06/17/2010WO2010022055A3 1, 3, 5 -triaz ine derivatives useful in the treatment of chronic pain disorders
06/17/2010US20100152444 Novel pyridazine compound and use thereof
06/17/2010US20100152438 Amphiphilic molecular modules and constructs based thereon
06/17/2010US20100152233 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
06/17/2010US20100152232 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
06/17/2010US20100152230 Hydroxy substituted 1h-imidazopyridines and methods
06/17/2010US20100152229 Process for the Synthesis of Moxifloxacin Hydrochloride
06/17/2010US20100152225 Hydrogenated pyrido [4,3-b] indoles such as dimebon for treating canine cognitive dysfunction syndrome
06/17/2010US20100152219 Pyrazole derivatives as inhibitors of receptor tyrosine kinases
06/17/2010US20100152216 Monocyclic anilide spirolactam cgrp receptor antagonists
06/17/2010US20100152206 Bicyclic Dihydropyrimidines and Uses Thereof
06/17/2010US20100152192 Fused imidazole carboxamides as trpv3 modulators
06/17/2010US20100152184 Pharmaceutical compounds
06/17/2010US20100152178 Imidazole derivatives
06/17/2010US20100152177 Compounds having 5-ht6 receptor affinity
06/17/2010US20100152171 CGRP Antagonists
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152165 Carboxylic acid derivatives
06/17/2010US20100150827 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancer
06/17/2010CA2748691A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010CA2746394A1 Spiroheterocyclic n-oxypiperidines as pesticides
06/17/2010CA2745922A1 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
06/16/2010EP2196466A1 Triple substituted phenanthroline derivatives for the treatment of neurodegenerative or heamatological diseases or conditions
06/16/2010EP2195318A2 Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes
06/16/2010EP2195316A1 Activators and therapeutic applications thereof
06/16/2010EP2194980A1 Fluoro-containing derivatives of hydrogented pyridoý4,3-b¨indoles with neuroprotective and cognition enhancing properties, process for preparing, and use
06/16/2010CN1982308B Substituted pyrazoles
06/16/2010CN1930162B Tetrahydropyridoindole derivatives
06/16/2010CN1925855B Compounds and methods for development of Ret modulators
06/16/2010CN1922189B Spirocyclic cyclohexane derivatives with affinity for the ORL1-receptor
06/16/2010CN1894258B Compositions useful as inhibitors of protein kinases
06/16/2010CN1830978B Pyrazolo [4,3-c]-quinolin-3-one compound, preparation method and use thereof
06/16/2010CN1694871B Imidazolopyridines and methods of making and using the same
06/16/2010CN101743246A 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents
06/16/2010CN101735217A Application of imidazole [4,5-f][1,10] phenanthroline and derivative thereof to preparation of antineoplastic drug
06/16/2010CN101735216A Europium complex silicon dioxide fluorescent nano particles and preparation method thereof
06/16/2010CN101735215A Beta-carboline cyclosubstituted carbamide class raf kinase suppressor, preparation method and application thereof
06/16/2010CN101225092B Manganese complex as well as preparation method and uses thereof
06/16/2010CN101048403B Heterocyclic antiviral compounds
06/16/2010CN101010323B Bicyclononene derivatives as renin inhibitors
06/15/2010US7737279 1,6-dihydro-N,1-dimethyl-7-phenyl imidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine, used for treating cancer, inflammatory and autoimmune diseases
06/15/2010US7737162 Viral inhibitors
06/15/2010US7737159 such as 2-(3-(aminomethyl)pyrrolidin-1-yl)-4-(4-methoxybenzyl)-7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acid, used for treating drug-resistant bacterial infections
06/15/2010US7737153 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
06/15/2010US7737143 such as 6-(1H-Benzimidazol-1-yl)-N-benzylpyrazin-2-amine, used as antidiabetic, anticarcinogenic and antiarthritic agents or for treating autoimmune diseases
06/15/2010US7737136 high affinity agonists; high specificity; side effect reduction; endometriosis; hormone dependent cancers, fertility control; dibenzo[b,f]pyrido[1,2-d][1,4] oxazepin, dibenzo[b,f]pyrido[1,2-d][1,4]thiazepim, dibenzo[b,f]pyrido[1,2-d][1,4]diazepin and dibenzo[c,f]pyrido[1,2-a]azepine derivatives
06/15/2010CA2538915C [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
06/15/2010CA2518224C Novel isothiazolopyrimidinones and isoxazolopyrimidinones and uses thereof
06/15/2010CA2393650C Novel 1,8-naphthyridin-2(1h)-one derivatives
06/15/2010CA2379103C Novel spiro compounds
06/15/2010CA2351714C Semi-hydrochloride of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
06/15/2010CA2299495C Process for preparing growth hormone secretagogues
06/10/2010WO2010065803A1 Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
06/10/2010WO2010065760A1 Imidazo [1,2a] pyridine derivatives, their use as s1p1 agonists and methods for their production
06/10/2010WO2010065701A1 Novel polymorphic forms of an azabicyclo-trifluoromethyl benzamide derivative
06/10/2010WO2010064735A1 Quinolone compound and pharmaceutical composition
06/10/2010WO2010064020A1 Imidazopyridine compounds
06/10/2010WO2010063876A1 Imidazopyridine derivatives which inhibit the secretion of gastric acid
06/10/2010WO2010063784A1 Novel diaza-bicyclononyl-phenyl derivatives and their medical use
06/10/2010WO2010063670A1 Spiroheterocyclic n-oxyamides as pesticides
06/10/2010WO2010063461A1 Bridged pyridoquinazoline or phenanthroline compounds and organic semiconduting material comprising that compound
06/10/2010WO2010063352A1 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer
06/10/2010US20100145054 Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same
06/10/2010US20100145052 Fused tricyclic compound having aldose reductase inhibitory activity
06/10/2010US20100145050 Orthogonally fixed compounds for electrooptical applications
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100145042 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
06/10/2010US20100145040 Benzazepine Derivatives For The Treatment of Neurological Disorders
06/10/2010US20100144823 Novel indole derivatives as selective androgen receptor modulators (sarms)
06/10/2010US20100144782 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
06/10/2010US20100144779 Marine Alkalod Makaluvamines and Derivatives Thereof
06/10/2010US20100144778 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment